DanGer Shock RCT: A Decade of Data – From Evidence to Everyday Practice
-
11m 16sPart 1 | Session 2 Key Results Overview
-
11m 37sPart 1 | Session 3 European and Global Perspectives: Country and Global Level Impact
-
1m 31s
-
3m 24sPart 2 | Session 2 What do you currently do with the intubated or non-responsive patients?
-
2m 4sPart 2 | Session 3 Is there anything you would like to see change in clinical practice?
-
5m 20sPart 2 | Session 5 Future research & Educational need
-
11m 32s
Gain critical insights into how the landmark DanGer Shock RCT reshaped cardiogenic shock management, improved patient outcomes and enhanced collaborative care strategies in real-world settings.
In this webinar, leading experts and trial investigators Dr Jacob Møller (Copenhagen University Hospital, Copenhagen, DK), Dr Vasileios Panoulas (Harefield Hospital, London, UK), Prof Christian Schulze (University Hospital Jena, Jena, DE), alongside moderator Dr Andreas Goetzenich (Senior Director, Medical & Scientific Office, Johnson & Johnson MedTech Heart Recovery), discussed the trial’s decade-long impact¹ on clinical decision-making and its application on a regional level.
The session examined how DanGer Shock continued to shape global practice, refine treatment algorithms and guide future research in cardiogenic shock management. The programme was of particular educational benefit for interventional cardiologists, cardiothoracic surgeons, intensivists, heart failure specialists and the multidisciplinary shock team.
Reference:
- Long-Term Outcomes of the DanGer Shock Trial, N Engl J Med 2025;393:1037-1038. DOI: 10.1056/NEJMc2508284
Learning Objectives
- Review key outcomes and the value of long-term data in clinical and operational decision-making
- Regional insights and best practices from across EMEA
- Apply evidence-based strategies to optimise cardiogenic shock management
- Challenges and opportunities in leveraging longitudinal data
- Integrate multidisciplinary collaboration into clinical workflows
- Explore future directions in cardiogenic shock care
Target Audience
- Interventional Cardiologists
- Cardiothoracic Surgeons
- Heart Failure Specialists / Cardiologists
- Non-invasive Cardiologists
- Intensive Care Nurses
- Anaesthetists
- Vascular Surgeons
- CT Technologists
More from this programme
Part 1
DanGer Shock RCT: A Decade of Data – From Evidence to Everyday Practice
Part 2
Expert Q&A
Faculty Biographies
Jacob E Møller
Clinical Professor, Chief Physician, PhD, Research Director
Prof Jacob Møller is clinical professor at the Odense University Hospital in Denmark. His main research interests include cardiogenic shock, mechanical circulatory support and invasive hemodynamic testing.
Vasileios Panoulas
Consultant Cardiologist
Dr Vasileios Panoulas is a consultant cardiologist based at Harefield Hospital, Harefield, UK.
He is also an honorary senior clinical lecturer at Imperial College London.
Christian Schulze
Professor of Medicine and Chair of the Department of Medicine I and Division of Cardiology
Professor Christian Schulze is a renowned cardiologist and researcher based in Germany, serving as Director of the Department of Internal Medicine and Cardiology at the University Hospital Jena. His clinical and scientific work focuses on heart failure, myocardial remodelling, and translational cardiovascular medicine. Professor Schulze has made significant contributions to understanding molecular mechanisms driving cardiac dysfunction and to developing novel therapeutic strategies for advanced heart disease. He is also an active member of several national and international cardiovascular societies, promoting excellence in research, education, and patient care.
Andreas Goetzenich
Senior Director
Dr Andreas Goetzenich is Senior Director, Medical & Scientific Office, Johnson & Johnson MedTech Heart Recovery.